CA2013809A1 - Agent for the Prophylaxis of Atopy and Methods for Preparing and Using Same - Google Patents

Agent for the Prophylaxis of Atopy and Methods for Preparing and Using Same

Info

Publication number
CA2013809A1
CA2013809A1 CA2013809A CA2013809A CA2013809A1 CA 2013809 A1 CA2013809 A1 CA 2013809A1 CA 2013809 A CA2013809 A CA 2013809A CA 2013809 A CA2013809 A CA 2013809A CA 2013809 A1 CA2013809 A1 CA 2013809A1
Authority
CA
Canada
Prior art keywords
gamma
linolenic acid
atopy
agent
glycolipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2013809A
Other languages
French (fr)
Other versions
CA2013809C (en
Inventor
Bodo Melnik
Gerd Plewig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3910761A external-priority patent/DE3910761A1/en
Priority claimed from DE3910760A external-priority patent/DE3910760A1/en
Application filed by Individual filed Critical Individual
Publication of CA2013809A1 publication Critical patent/CA2013809A1/en
Application granted granted Critical
Publication of CA2013809C publication Critical patent/CA2013809C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

The subject invention provides an agent and a method for atopy prophylaxis. Supplying gamma-linolenic acid, dihomo-gamma-linolenic acid, the physiologically compatible salts, esters, amides, phospholipids, glycolipids thereof, and Prostaglandin E1 (PGE1), PGE1 derivatives, PGE1 analogs to babies can prevent a subsequent occurrence of manifest atopy forms. The agents according to the invention are preferably contained in a baby food and/or should be supplied to the baby together therewith.
In a further preferred embodiment the agent contains a thymus hormone, or thymus hormones provided in combination with the agent. Further provided for is the use of Prostaglandin E1, its derivatives and analogs and the physiologically compatible esters, amides, phospholipids and glycolipids thereof in a pharmacologically effective dosage form for the topical or inhalative treatment of acute manifest atopy in the dermal and mucosal areas. The substance used according to the invention are preferably used in combination with gamma-linolenic acid, 15-hydroxydihomo-gamma-linolenic acid and dihomo-gamma-linolenic acid, the physiologically compatible salts, esters, amides, phospholipids and glycolipids thereof.
CA002013809A 1989-04-04 1990-04-04 Agent for the prophylaxis of atopy and methods for preparing and using same Expired - Fee Related CA2013809C (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DEP3910761.2 1989-04-04
DEP3910760.4 1989-04-04
DE3910761A DE3910761A1 (en) 1989-04-04 1989-04-04 Composition for atopy prophylaxis
DE3910760A DE3910760A1 (en) 1989-04-04 1989-04-04 NEW USE OF KNOWN SUBSTANCES AND METHOD FOR THE PRODUCTION OF SUITABLE PREPARATIONS
DEP3930816.2 1989-09-14
DE3930816 1989-09-14

Publications (2)

Publication Number Publication Date
CA2013809A1 true CA2013809A1 (en) 1990-10-04
CA2013809C CA2013809C (en) 1996-12-17

Family

ID=27199345

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002013809A Expired - Fee Related CA2013809C (en) 1989-04-04 1990-04-04 Agent for the prophylaxis of atopy and methods for preparing and using same

Country Status (1)

Country Link
CA (1) CA2013809C (en)

Also Published As

Publication number Publication date
CA2013809C (en) 1996-12-17

Similar Documents

Publication Publication Date Title
KR870010862A (en) Nasal Aqueous Steroid Formulations
GB8623557D0 (en) Therapeutic agents
EG17609A (en) Process for preparation of therapeutic agents from derivatives of propoimic acid.
TW336171B (en) Pharmaceutical composition for use in the treatment of vulvar dystrophy and/or vaginal dryness
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
EP0391218A3 (en) Agent for the atopy prophylaxis
GB8607137D0 (en) Compositions
KR910005858A (en) Fatty acid therapy
ATE135909T1 (en) METHOD FOR TREATING ACNE
GB1458414A (en) Composition and method of treatin ulcers
CA2013809A1 (en) Agent for the Prophylaxis of Atopy and Methods for Preparing and Using Same
ES2052000T3 (en) PROCEDURE FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING PENTAMIDINE.
GB8916734D0 (en) Pharmaceutical and dietary uses of fatty acids
HUT52388A (en) Process for producing pharmaceutical compositions comprising unsaturated fatty acids and selenium as active ingredient
JPS5441320A (en) Slow release preparation and its manufacturing
EP0310126A3 (en) Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines
EP0399175A3 (en) Pge1 and derivatives for dermal or mucosal application
ATE184489T1 (en) TREATMENT OF LACK OF MILK SECTION IN HUMAN BEINGS
GR3021544T3 (en) An antiviral agent derived from the hull of the kukui nut
ATE86965T1 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF ADRENOLEUCODYSTROPHY.
EP0144489A3 (en) Cerebral and peripheral antihypoxidoticum
JPS5659714A (en) Improver and remedy for dysbulia or depression
DE59002790D1 (en) Process for the preparation of a galenic preparation with optimal bioavailability of the active ingredient 2-hydroxy-5-methyllaurophenonoxime (HMLO).
JPS643123A (en) Remedy for skin inflammation
IT1261938B (en) Use of carboxylic acids having from 7 to 13 carbon atoms and their physiologically acceptable salts for the production of a drug for the topical treatment of antibiotic-resistant osteomyelitis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed